Literature DB >> 6360905

A small plasmid in Shigella dysenteriae 1 specifies one or more functions essential for O antigen production and bacterial virulence.

H Watanabe, K N Timmis.   

Abstract

The role of plasmids in the virulence of Shigella dysenteriae 1 W30864, which contains at least five species, was investigated. By means of a standard plasmid-curing procedure, that is, bacterial cultivation at an elevated temperature, five virulence-deficient derivatives were obtained. One of these lacked a small, 6-megadalton plasmid, designated pHW400, exhibited reduced invasiveness for HeLa cells, and failed to produce the somatic antigen. Transposon tagging of the pHW400 plasmid to produce pHW401 and the transfer of this derivative into a variant of strain W30864 lacking pHW400 confirmed the conclusion that the pHW400 plasmid encodes one or more functions involved in O antigen (lipopolysaccharide) biosynthesis and bacterial virulence. A plasmid of similar size was detected in all of the three other strains of S. dysenteriae 1 examined.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6360905      PMCID: PMC263439          DOI: 10.1128/iai.43.1.391-396.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Application of experimental keratoconjunctivitis shigellosa in chemotherapeutic evaluation of rifampicin to bacillary dysentery.

Authors:  Y Osada; M Nakajo; H Ogawa
Journal:  Jpn J Microbiol       Date:  1972-07

Review 2.  Bacteriophage receptors.

Authors:  A A Lindberg
Journal:  Annu Rev Microbiol       Date:  1973       Impact factor: 15.500

3.  Recombination between two IS/s flanking the r-determinant of R100-1: involvement of dor and recA gene functions in Salmonella typhimurium.

Authors:  H Watanabe; K Mise; H Hashimoto
Journal:  J Bacteriol       Date:  1982-04       Impact factor: 3.490

4.  Rapid procedure for detection and isolation of large and small plasmids.

Authors:  C I Kado; S T Liu
Journal:  J Bacteriol       Date:  1981-03       Impact factor: 3.490

5.  Adherence of Shigella flexneri to guinea pig intestinal cells is mediated by a mucosal adhesion.

Authors:  M Izhar; Y Nuchamowitz; D Mirelman
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

6.  Characterization of virulence plasmids and plasmid-associated outer membrane proteins in Shigella flexneri, Shigella sonnei, and Escherichia coli.

Authors:  T L Hale; P J Sansonetti; P A Schad; S Austin; S B Formal
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

7.  Genetic and physical evidence for plasmid control of Shigella sonnei form I cell surface antigen.

Authors:  D J Kopecko; O Washington; S B Formal
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

8.  ABORTIVE INTESTINAL INFECTION WITH AN ESCHERICHIA COLI-SHIGELLA FLEXNERI HYBRID STRAIN.

Authors:  S B FORMAL; E H LABREC; T H KENT; S FALKOW
Journal:  J Bacteriol       Date:  1965-05       Impact factor: 3.490

9.  HeLa cell invasiveness and O antigen of Shigella flexneri as separate and prerequisite attributes of virulence to evoke keratoconjunctivitis in guinea pigs.

Authors:  N Okamura; T Nagai; R Nakaya; S Kondo; M Murakami; K Hisatsune
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

10.  Involvement of a plasmid in the invasive ability of Shigella flexneri.

Authors:  P J Sansonetti; D J Kopecko; S B Formal
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

View more
  28 in total

1.  Plasmid profiles of antibiotic-resistant Shigella dysenteriae types 2, 3, 4, 6 and 7 isolated in Ethiopia during 1976-85.

Authors:  A Gebre-Yohannes; B S Drasar
Journal:  Epidemiol Infect       Date:  1990-08       Impact factor: 2.451

Review 2.  Genetic basis of virulence in Shigella species.

Authors:  T L Hale
Journal:  Microbiol Rev       Date:  1991-06

Review 3.  Genetics of lipopolysaccharide biosynthesis in enteric bacteria.

Authors:  C A Schnaitman; J D Klena
Journal:  Microbiol Rev       Date:  1993-09

4.  Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1.

Authors:  S R Klee; B D Tzschaschel; I Fält; A Kärnell; A A Lindberg; K N Timmis; C A Guzmán
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Plasmid analysis of Shigella dysenteriae type 1 isolates obtained from widely scattered geographical locations.

Authors:  K Haider; B A Kay; K A Talukder; M I Huq
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

6.  Small virulence plasmid of Shigella dysenteriae 1 strain W30864 encodes a 41,000-dalton protein involved in formation of specific lipopolysaccharide side chains of serotype 1 isolates.

Authors:  H Watanabe; A Nakamura; K N Timmis
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

7.  Expression of lipopolysaccharide O antigen in Escherichia coli K-12 hybrids containing plasmid and chromosomal genes from Shigella dysenteriae 1.

Authors:  T L Hale; P Guerry; R C Seid; C Kapfer; M E Wingfield; C B Reaves; L S Baron; S B Formal
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Lateral transfer of rfb genes: a mobilizable ColE1-type plasmid carries the rfbO:54 (O:54 antigen biosynthesis) gene cluster from Salmonella enterica serovar Borreze.

Authors:  W J Keenleyside; C Whitfield
Journal:  J Bacteriol       Date:  1995-09       Impact factor: 3.490

9.  Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid.

Authors:  C Y Chu; B K Liu; D Watson; S S Szu; D Bryla; J Shiloach; R Schneerson; J B Robbins
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

10.  Plasmid-encoded expression of lipopolysaccharide O-antigenic polysaccharide in enteropathogenic Escherichia coli.

Authors:  L W Riley; L N Junio; L B Libaek; G K Schoolnik
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.